Thrombocytopenia Induced by Chemotherapy
NCT03567798 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2018-06-27
Summary
Single blind, randomized, multicentric placebo controlled study to evaluate the efficacy of Study product in patient with Chemotherapy induced thrombocytopenia. The Study is divided into \[screening visit (visit 1) \> baseline and treatment allocation visit (visit 2) \>blood collection (visit 3); treatment compliance visit (visit 4) \> blood collection (visit 5) \>blood collection (visit 6)\>end of study visit (visit 7)\].
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
UPLAT
Carica papaya leaf Extract + Tinospora cardifolia Extract
- OTHER
-
Placebo
Placebo
Sponsors & Collaborators
-
Socrates School Of Health
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-18
- Primary Completion
- 2017-11-20
- Completion
- 2017-11-20
Countries
- India
Study Locations
More Related Trials
-
Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.
NCT05864014 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Herombopag for Chemotherapy-induced Thrombocytopenia
NCT05236582 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia
NCT02093325 ·Status: UNKNOWN ·Phase: PHASE3
-
Romiplostim N01 for Chemotherapy-induced Thrombocytopenia
NCT07063225 ·Status: RECRUITING ·Phase: PHASE2
-
Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma
NCT04797182 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia
NCT04896528 ·Status: UNKNOWN ·Phase: PHASE2
-
Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia
NCT01491594 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
NCT00039910 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy
NCT01319669 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury
NCT05411705 ·Status: RECRUITING ·Phase: PHASE4
-
Study of Romiplostim for Chemotherapy Induced Thrombocytopenia
NCT02052882 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
NCT00037791 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia
NCT06562738 ·Status: RECRUITING ·Phase: PHASE4
-
A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer
NCT05394285 ·Status: COMPLETED ·Phase: PHASE2
-
to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection
NCT03664518 ·Status: COMPLETED ·Phase: PHASE2
-
Study on the Efficacy and Safety of Avatricopal in Patients With CLD Complicated With Thrombocytopenia
NCT06642740 ·Status: ENROLLING_BY_INVITATION
-
High-dose Use of rhTPO in CIT Patients
NCT03633019 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Study of Herombopag in Tumors-associated Thrombocytopenia
NCT05350956 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure
NCT04915287 ·Status: UNKNOWN ·Phase: PHASE4
-
Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months
NCT04516967 ·Status: COMPLETED ·Phase: PHASE3
-
Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study
NCT07243418 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients
NCT05217719 ·Status: UNKNOWN ·Phase: PHASE4
-
Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia
NCT01763658 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Platelet Augmentation Using C. Papaya Leaf Extract in Live Donor Liver Transplantation
NCT05360134 ·Status: UNKNOWN ·Phase: NA
-
Bleeding In Thrombocytopenia Explained
NCT03505086 ·Status: RECRUITING